# Application of ICG@HSA Complexes in Fluorescence Image-Guided Laparoscopic Anatomical Liver Resection

> **NCT06219096** · NA · RECRUITING · sponsor: **West China Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Malignant Tumor of Liver
- Randomized Controlled Trial

## Interventions

- **PROCEDURE:** NIF image-guided laparoscopic anatomical liver resection with the novel ICG@HSA administration
- **PROCEDURE:** NIF image-guided laparoscopic anatomical liver resection with the guideline-recommended ICG administration

## Key facts

- **NCT ID:** NCT06219096
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-10
- **Primary completion:** 2026-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-01-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06219096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06219096, "Application of ICG@HSA Complexes in Fluorescence Image-Guided Laparoscopic Anatomical Liver Resection". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06219096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*